Clinical Hours: Mon-Fri, 8AM - 3PM(905) 493-5700
1885 Glenanna Road, Suite 220, Pickering, ON, L1V 6R6
Pyogenic granuloma is a rapidly growing, benign vascular skin lesion that bleeds easily and typically requires surgical removal for definitive treatment.
Pyogenic granuloma (lobular capillary haemangioma) is a common, rapidly growing, benign vascular tumour of the skin and mucous membranes. Despite its name, the lesion is neither pyogenic (pus-forming) nor a true granuloma. It consists of a proliferation of capillary blood vessels arranged in a lobular pattern, surrounded by loose connective tissue stroma.
Pyogenic granulomas can occur at any age, including in infants and children, but are most commonly seen in children and young adults. The condition affects both sexes, with a slight female predominance overall and a notable association with pregnancy. Lesions grow rapidly over days to weeks, often reaching their full size within a few weeks of onset. The hallmark clinical feature is the tendency for profuse bleeding with minimal trauma, which frequently prompts medical consultation.
The pathogenesis of pyogenic granuloma involves a reactive vascular proliferation, likely triggered by local factors that promote angiogenesis (new blood vessel formation). The precise mechanism is not fully understood, but the lesion is considered a reactive process rather than a true neoplasm.
Factors associated with the development of pyogenic granulomas include:
Pyogenic granulomas are not caused by infection and are not contagious. In many cases, no identifiable trigger is found.
Pyogenic granulomas present with distinctive clinical features:
The rapid growth pattern is characteristic and may cause alarm, as malignant lesions can also grow quickly. Pyogenic granulomas typically reach a stable size within a few weeks and then persist without further growth. Spontaneous regression is possible but uncommon, and recurrence after incomplete removal is well documented.
The diagnosis of pyogenic granuloma is often made clinically based on the characteristic rapid growth, friable vascular appearance, and tendency for bleeding. However, histopathological confirmation is strongly recommended for all excised lesions, as the clinical appearance can overlap with several important differential diagnoses.
A skin biopsy or excision specimen sent for histopathological examination reveals a lobular arrangement of capillary blood vessels separated by fibromyxoid stroma, with an overlying thinned or ulcerated epidermis. This lobular capillary pattern is diagnostic.
The most important differential diagnosis is amelanotic (non-pigmented) melanoma, which can closely mimic a pyogenic granuloma as a rapidly growing, bleeding, red nodule. This clinical overlap makes histopathological examination essential, as a missed melanoma has serious consequences. Other conditions in the differential diagnosis include squamous cell carcinoma (particularly the keratoacanthoma variant), Kaposi sarcoma, bacillary angiomatosis (in immunosuppressed patients), and haemangioma.
Treatment of pyogenic granuloma is recommended to control bleeding, prevent recurrence, obtain tissue for histopathological confirmation, and rule out malignancy. Several effective treatment methods are available.
Shave excision followed by electrosurgery (electrocautery) of the base is one of the most commonly performed procedures for pyogenic granuloma. The lesion is shaved at its base under local anaesthesia, and the base is cauterised to destroy residual vascular tissue and achieve haemostasis. This technique provides a tissue specimen for histological examination and has a relatively low recurrence rate.
Full-thickness surgical excision with primary closure provides the lowest recurrence rate and the most complete tissue specimen for histopathological analysis. This approach is preferred for larger lesions, recurrent lesions, and cases where the clinical diagnosis is uncertain. Excision ensures that the entire lesion, including any deep component, is removed.
Curettage (scraping) of the lesion followed by cauterisation of the base is an effective technique, particularly for small to medium-sized lesions. This approach combines thorough removal of the vascular tissue with cautery to reduce the risk of recurrence and control bleeding. However, it may not always provide an intact tissue specimen suitable for histological assessment.
Laser ablation using pulsed dye laser or Nd:YAG laser may be effective for small pyogenic granulomas, particularly in cosmetically sensitive areas. Cryotherapy with liquid nitrogen can be used for small lesions but has a higher recurrence rate. For recurrent lesions at a site, silver nitrate application or topical timolol (a beta-blocker) has been reported as beneficial in some cases. In pregnancy-associated gingival lesions, observation may be appropriate as many will regress after delivery.
Recurrence is the most common complication following treatment, occurring in approximately 15% to 20% of cases, and is more frequent with incomplete removal. Satellite lesions (multiple small pyogenic granulomas developing around the treatment site) may occasionally develop following removal of the primary lesion.
Prompt dermatological assessment is recommended for any rapidly growing skin lesion, particularly if it bleeds easily or repeatedly. Given the clinical overlap between pyogenic granuloma and amelanotic melanoma, professional evaluation and histopathological confirmation are essential for all rapidly growing vascular nodules. Lesions that recur after treatment or that develop unusual features (irregular borders, variable colouration, persistent growth beyond the initial rapid phase) should be re-evaluated without delay.
A referral from a family physician is the standard pathway to access specialist dermatology care. Dr. Maksym Breslavets at the Centre for Medical and Surgical Dermatology provides specialist evaluation and surgical management of pyogenic granulomas, including excision, shave removal with cautery, and histopathological assessment to exclude malignancy.
Your feedback helps us improve our condition information
A physician referral is required to access our medical services. Contact your primary care provider to begin the referral process.